A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2004
12/30/2004	US20040265833 Such as carcinomas, adenomas, and polyps; peptide nucleic acids; solid phase synthesis; microarrays; kits
12/30/2004	US20040265821 Rna amplication system using plant components in animal cells
12/30/2004	US20040265808 Genes involved in osteogenesis, and methods of use
12/30/2004	US20040265804 Method for identifying metastatic tumor cells
12/30/2004	US20040265803 for the prevention, diagnosis and/or therapy of MSI+ tumors; antibodies against the gene product; use as antitumor agents or vaccines
12/30/2004	US20040265798 expression cassettes including nucleic acid elements for enhancing the titer of pseudotyped viral particles; heterologous envelope glycoprotein derived from a Jaagsiekte sheep retrovirus (JSRV env); use in gene therapy
12/30/2004	US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
12/30/2004	US20040265336 Multivalent vaccination using recombinant adenovirus
12/30/2004	US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
12/30/2004	US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/30/2004	US20040265311 Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity
12/30/2004	US20040265310 Novel prostate-restricted gene expressed in prostate cancer
12/30/2004	US20040265308 Prevention and treatment of amyloidogenic disease
12/30/2004	US20040265288 A engineered cell or recombinant virus as biodrug for the treatment of cancer, HIV infection, multiple sclerosis; drug target
12/30/2004	US20040265287 Myocardial grafts and cellular compositions useful for same
12/30/2004	US20040265285 Deleting lympocytes and reactivating thymus via CD34-antigens and/or leutininzing hormone releasing hormone agonists (sex steroids); for alleviation of autoimmune diseases and allergies
12/30/2004	US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
12/30/2004	US20040265283 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage)
12/30/2004	US20040265276 Medicinal combination useful for in vivo exogenic transfection and expression
12/30/2004	US20040265275 Polypeptide
12/30/2004	US20040265273 gene therapy; nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; antimetastasis; murine urokinase ATF expressed by tumor cells in an athymic murine model unexpectedly effectively inhibits tumorigenicity
12/30/2004	US20040265230 Compositions and methods for diagnosing and treating colon cancers
12/30/2004	US20040264853 Light probe for ultraviolet light activated gene transduction
12/29/2004	WO2004113524A1 Variants of aminoacylase, nucleic acids coding same, and uses thereof
12/29/2004	WO2004113517A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
12/29/2004	WO2004113497A2 Gene delivery to tumors
12/29/2004	WO2004113384A1 Use of a vegf receptor gene or gene product
12/29/2004	WO2004113379A1 Interferon gamma-like protein
12/29/2004	WO2004112825A2 Combinations of tumor-associated antigens for the treatment of various types of cancers
12/29/2004	WO2004112823A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	WO2004112575A2 Gene amplification and overexpression in cancer
12/29/2004	WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax
12/29/2004	WO2004033664A3 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
12/29/2004	WO2004016803A3 Method of enhancing cd4+ t cell responses
12/29/2004	WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use
12/29/2004	WO2003087128A3 Secretory signal sequences and uses thereof
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491217A1 Stabilization of polynucleotide complexes
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491214A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490692A2 Diagnostic and therapeutic use of caps
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490495A2 Bone generation by gene therapy
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490490A2 Antisense iap nucleobase oligomers and uses thereof
12/29/2004	EP1490489A1 Methods and means for monitoring and modulating gene silencing
12/29/2004	EP1490484A2 Further bmp-2 inducible kinases and the uses thereof
12/29/2004	EP1490478A2 Method for production of neutrophils and uses therefor
12/29/2004	EP1490473A1 Bacterial spores
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490387A2 A human ribonucleotide reductase m2 subunit
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490113A2 Raav vector compositions and methods for the treatment of choroidal neovascularization
12/29/2004	EP1490112A1 Method and agent for producing therapeutically active blood compositions
12/29/2004	EP1490107A1 Modulating angiogenesis
12/29/2004	EP1490105A2 Multiple and multivalent dna vaccines in ovo
12/29/2004	EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004	EP1490100A2 Combined dna/protein vaccine compositions
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490075A2 Bioadhesive directed somatic cell therapy
12/29/2004	EP1490074A2 Mixed- cell gene therapy
12/29/2004	EP1490013A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004	EP1146909A4 Method of treating cancer by restoration of pp32 function
12/29/2004	EP1123509B1 Methods of diagnosing or prognosing alzheimer's disease
12/29/2004	EP1084251B1 Attenuated pestiviruses
12/29/2004	EP1071768B1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
12/29/2004	EP1062321B1 Uses for humane non-autologous mesenchymal stem cells
12/29/2004	EP0994725B1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION
12/29/2004	CN1559047A DNA providing system
12/29/2004	CN1557486A Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CA2529142A1 Rna interferases and methods of use thereof
12/29/2004	CA2529056A1 Combinations of tumor-associated antigens in compositions for various types of cancers
12/29/2004	CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	CA2528529A1 Gene amplification and overexpression in cancer
12/29/2004	CA2528002A1 Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
12/29/2004	CA2527091A1 Interferon gamma-like protein
12/29/2004	CA2526643A1 Use of a vegf receptor gene or gene product
12/28/2004	US6835826 Acid resistance, stability; telomerase inhibitor
12/28/2004	US6835712 Compounds
12/28/2004	US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
12/28/2004	US6835555 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835380 Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/23/2004	WO2004111270A2 Differential gene expression in schizophrenia

1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 870